NEW
Stock Screener with Intrinsic Value
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$696.9(5.0%)
Market Cap$75.6B
4.3x
Industry median - 4.4x
5Y Historical average - 3.6x
(2.1x)
Industry median - 1.0x
5Y Historical average - (1.4x)
FCF to Interest
53.6x
Industry median - (28.9x)
5Y Historical average - 68.7x
9.2%
Industry median - 3.9%
5Y Historical average - 15.0%
REGN Health Rating
Crunching data... Almost there!
REGN Financial Stability & Strength
Crunching data... Almost there!
Competing with REGN Financial Health
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Regeneron Pharmaceuticals, Inc. (REGN) quick ratio?
The Regeneron Pharmaceuticals, Inc. (REGN) quick ratio is 4.3x, compared to the industry median of 4.4x and the 5-year historical average of 3.6x.
What is the Regeneron Pharmaceuticals, Inc. (REGN) net debt to Free Cash Flow (FCF) ratio?
The Regeneron Pharmaceuticals, Inc. (REGN) net debt to FCF ratio is (2.1x), compared to the industry median of 1.0x and the 5-year historical average of ((1.4x)).
What is Regeneron Pharmaceuticals, Inc. (REGN) Free Cash Flow (FCF) to interest ratio?
Regeneron Pharmaceuticals, Inc. (REGN) FCF to interest ratio is 53.6x, compared to the industry median of (28.9x) and the 5-year historical average of 68.7x.
What is the Regeneron Pharmaceuticals, Inc. (REGN) total debt to equity ratio?
The Regeneron Pharmaceuticals, Inc. (REGN) total debt to equity ratio is 9.2%, compared to the industry median of 3.9% and the 5-year historical average of 15.0%.